Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Frontiers in Public Health|November 7, 2024
Case study: lessons learned from a community-based early frailty intervention programme in SingaporeKamala Priya Jayaprakash, Rachel Ngo, Elianna Lee, et al.Analytical Biochemistry|November 8, 2011
Development of a time-resolved fluorescence resonance energy transfer assay for cyclin-dependent kinase 4 and identification of its ATP-noncompetitive inhibitorsMei-Chu Lo, Rachel Ngo, Kang Dai, et al.SLAS Discovery : Advancing Life Sciences R & D|May 9, 2024
Creating a more strategic small molecule biophysical hit characterization workflowChristopher Fotsch, Debaleena Basu, Ryan Case, et al.Molecular Cancer Therapeutics|February 15, 2014
Preclinical evaluation of AMG 925, a FLT3/CDK4 dual kinase inhibitor for treating acute myeloid leukemiaKathleen Keegan, Cong Li, Zhihong Li, et al.Journal of Medicinal Chemistry|March 18, 2025
From DNA-Encoded Library Screening to AM-9747: An MTA-Cooperative PRMT5 Inhibitor with Potent Oral In Vivo EfficacyIan Sarvary, Mikkel Vestergaard, Loris Moretti, et al.Journal of Medicinal Chemistry|March 27, 2025
Discovery of AMG 193, an MTA-Cooperative PRMT5 Inhibitor for the Treatment of MTAP-Deleted CancersLiping H Pettus, Matthew Bourbeau, Nuria A Tamayo, et al.Journal of Medicinal Chemistry|March 20, 2014
Discovery of AMG 925, a FLT3 and CDK4 dual kinase inhibitor with preferential affinity for the activated state of FLT3Zhihong Li, Xianghong Wang, John Eksterowicz, et al.Pageof 1